Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea
· Delayed Price · Currency is KRW
Full Chart
Watchlist
Alerts
Compare
17,990
-40 (-0.22%)
Sep 1, 2026, 3:30 PM KST
Overview
Financials
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
Onconic Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Current
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Aug '26
Aug 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Market Capitalization
816,887
869,777
176,537
-
-
-
Market Cap Growth
177.05%
392.69%
-
-
-
-
Enterprise Value
754,542
816,363
152,373
-
-
-
Last Close Price
17990.00
19550.00
4085.00
-
-
-
Price Ratios
Current
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Aug '26
Aug 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
PE Ratio
33.68
55.11
-
-
-
-
PS Ratio
9.94
16.29
11.90
-
-
-
PB Ratio
9.52
12.07
3.15
-
-
-
P/TBV Ratio
9.52
12.07
3.15
-
-
-
P/FCF Ratio
49.54
78.41
-
-
-
-
P/OCF Ratio
48.61
76.33
-
-
-
-
EV Ratios
Current
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Aug '26
Aug 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
EV/Sales Ratio
9.18
15.29
10.27
-
-
-
EV/EBITDA Ratio
42.22
62.09
-
-
-
-
EV/EBIT Ratio
43.61
64.69
-
-
-
-
EV/FCF Ratio
45.76
73.60
-
-
-
-
Financial Efficiency
Current
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Aug '26
Aug 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Debt / Equity Ratio
0.00
0.00
0.01
-0.06
0.00
-0.02
Debt / EBITDA Ratio
0.02
0.01
-
0.13
-
-
Debt / FCF Ratio
0.02
0.01
-
0.12
-
-
Net Debt / Equity Ratio
-0.73
-0.73
-0.76
5.05
1.24
2.34
Net Debt / EBITDA Ratio
-3.49
-4.00
9.82
-11.05
1.85
2.25
Net Debt / FCF Ratio
-3.78
-4.74
5.35
-9.97
1.56
2.11
Asset Turnover
1.05
0.78
0.30
0.62
0.00
-
Quick Ratio
11.32
17.48
10.61
0.71
1.06
36.08
Current Ratio
11.39
17.62
10.94
0.71
1.06
36.10
Return on Equity (ROE)
33.51%
24.65%
-32.29%
-
-
-
Return on Assets (ROA)
13.81%
11.55%
-6.09%
4.07%
-36.85%
-
Return on Capital Employed (ROCE)
20.10%
17.50%
-8.50%
-39.40%
-343.70%
-44.10%
Yields
Current
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Aug '26
Aug 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Earnings Yield
2.97%
1.81%
-4.58%
-
-
-
FCF Yield
2.02%
1.27%
-4.52%
-
-
-
Buyback Yield / Dilution
-
-38.72%
-41.46%
0.00%
-0.94%
-